Related content

The importance of IRS-1 Gly972Arg polymorphism in evaluating the response to metformin treatment in polycystic ovary syndrome

By Ertunc D.  

Human Reproduction, Vol. 20, Iss. 5, 2005-05 ,pp. : 1207-1212

Oxford University Press

Access to resources Recommend Favorite

Age- and body mass index-related differences in the prevalence of metabolic syndrome in women with polycystic ovary syndrome

By Panidis Dimitrios   Tziomalos Konstantinos   Macut Djuro   Kandaraki Eleni A.   Tsourdi Elena A.   Papadakis Efstathios   Katsikis Ilias  

Gynecological Endocrinology, Vol. 29, Iss. 10, 2013-10 ,pp. : 926-930

Informa Healthcare

Access to resources Recommend Favorite

Prevalence of the metabolic syndrome in Asian women with polycystic ovary syndrome: Using the International Diabetes Federation criteria

By Weerakiet Sawaek   Bunnag Pongamon   Phakdeekitcharoen Bunyong   Wansumrith Surapee   Chanprasertyothin Suwannee   Jultanmas Rattiya   Thakkinstian Ammarin  

Gynecological Endocrinology, Vol. 23, Iss. 3, 2007-03 ,pp. : 153-160

Informa Healthcare

Access to resources Recommend Favorite

Prevalence of metabolic syndrome in women with polycystic ovary syndrome, using two proposed definitions

By Bhattacharya Sudhindra Mohan  

Gynecological Endocrinology, Vol. 26, Iss. 7, 2010-07 ,pp. : 516-520

Informa Healthcare

Access to resources Recommend Favorite

The prevalence of metabolic syndrome in clomiphene citrate resistant polycystic ovary syndrome

By Verit Fatma Ferda  

Gynecological Endocrinology, Vol. 28, Iss. 5, 2012-05 ,pp. : 365-369

Informa Healthcare

Access to resources Recommend Favorite